Atorvastatin Combining with Probucol: A New Way to Reduce Serum Uric Acid Level during Perioperative Period of Interventional Procedure

Table 1

Baseline clinical, biochemical and procedural characteristics of the patients.

Variable	S-C group; (𝑛=55)	I-C group; (𝑛=79)	I-A group; (𝑛=74)	𝑃 value
Age (year)	62.33±9.49	60.65±10.11	61.00±10.23	0.616^a
Female gender	25 (45.45%)	33 (41.72%)	27 (36.49%)	0.579^b
Body mass index (kg/m^2)	27.24±10.23	25.96±3.51	28.35±17.26	0.454^a
Current smoking (𝑛)	19/34.55	33/41.77	36/48.65	0.274^b
Total cholesterol (mmol/L)	4.81±1.21	4.91±1.59	4.68±1.27	0.592^a
Triglyceride (mmol/L)	1.83±0.96	1.71±0.78	1.67±0.93	0.553^a
Low-density lipoprotein (mmol/L)	2.74±0.92	2.98±1.32	2.72±1.02	0.291^a
Blood glucose (mmol/L)	5.66±1.56	5.62±1.71	5.65±2.00	0.993^a
Red blood cell count (10^12/L)	4.50±0.76	4.53±0.41	4.35±0.46	0.116^a
White blood cell count (10^9/L)	6.91±1.53	7.29±1.87	7.73±1.92	0.211^a
Diabetes mellitus (𝑛)	11 (20.00%)	23 (29.11%)	16 (21.62%)	0.398^b
Volume of contrast agent (mL)	187.96±103.22	185.53±142.32	185.71±123.69	0.993^a
Hypertension (𝑛)	38 (69.09%)	53 (67.09%)	49 (66.22%)	0.548^b

Values are expressed as means ± SD or number (%) of patients. ^aBy Student’s 𝑡 test; ^bBy 𝜒² test.